Piperine metabolically regulates peritoneal resident macrophages to potentiate their functions against bacterial infection

Oncotarget. 2015 Oct 20;6(32):32468-83. doi: 10.18632/oncotarget.5957.

Abstract

Pepper, a daily-used seasoning for promoting appetite, is widely used in folk medicine for treating gastrointestinal diseases. Piperine is the major alkaloid in pepper and possesses a wide range of pharmacological activities. However, the mechanism for linking metabolic and medicinal activities of piperine remains unknown. Here we report that piperine robustly boosts mTORC1 activity by recruiting more system L1 amino acid transporter (SLC7A5/SLC3A2) to the cell membrane, thus promoting amino acid metabolism. Piperine-induced increase of mTORC1 activity in resident peritoneal macrophages (pMΦs) is correlated with enhanced production of IL-6 and TNF-α upon LPS stimulation. Such an enhancement of cytokine production could be abrogated by inhibitors of the mTOR signaling pathway, indicating mTOR's action in this process. Moreover, piperine treatment protected resident pMΦs from bacterium-induced apoptosis and disappearance, and increased their bacterial phagocytic ability. Consequently, piperine administration conferred mice resistance against bacterial infection and even sepsis. Our data highlight that piperine has the capacity to metabolically reprogram peritoneal resident macrophages to fortify their innate functions against bacterial infection.

Keywords: Immune response; Immunity; Immunology and Microbiology Section; SLC7A5/SLC3A2; bacterial infection; mTORC1; peritoneal macrophages; piperine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaloids / pharmacology*
  • Amino Acids / metabolism*
  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • Apoptosis / drug effects
  • Benzodioxoles / pharmacology*
  • Disease Models, Animal
  • Escherichia coli / drug effects*
  • Escherichia coli / immunology
  • Escherichia coli / pathogenicity
  • Escherichia coli Infections / immunology
  • Escherichia coli Infections / metabolism
  • Escherichia coli Infections / microbiology
  • Escherichia coli Infections / pathology
  • Escherichia coli Infections / prevention & control*
  • Female
  • Fusion Regulatory Protein 1, Heavy Chain / metabolism
  • HeLa Cells
  • Humans
  • Immunity, Innate / drug effects
  • Inflammation Mediators / metabolism
  • Interleukin-6 / metabolism
  • Large Neutral Amino Acid-Transporter 1 / genetics
  • Large Neutral Amino Acid-Transporter 1 / metabolism
  • Lipopolysaccharides / pharmacology
  • Macrophage Activation / drug effects*
  • Macrophages, Peritoneal / drug effects*
  • Macrophages, Peritoneal / immunology
  • Macrophages, Peritoneal / metabolism
  • Macrophages, Peritoneal / microbiology
  • Macrophages, Peritoneal / pathology
  • Male
  • Mechanistic Target of Rapamycin Complex 1
  • Mice
  • Mice, Inbred C57BL
  • Multiprotein Complexes / metabolism
  • Phagocytosis / drug effects
  • Piperidines / pharmacology*
  • Polyunsaturated Alkamides / pharmacology*
  • RAW 264.7 Cells
  • RNA Interference
  • Signal Transduction / drug effects
  • TOR Serine-Threonine Kinases / metabolism
  • Time Factors
  • Transfection
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Alkaloids
  • Amino Acids
  • Anti-Bacterial Agents
  • Benzodioxoles
  • Fusion Regulatory Protein 1, Heavy Chain
  • Inflammation Mediators
  • Interleukin-6
  • Large Neutral Amino Acid-Transporter 1
  • Lipopolysaccharides
  • Multiprotein Complexes
  • Piperidines
  • Polyunsaturated Alkamides
  • Slc3A2 protein, mouse
  • Tumor Necrosis Factor-alpha
  • interleukin-6, mouse
  • lipopolysaccharide, Escherichia coli O111 B4
  • Mechanistic Target of Rapamycin Complex 1
  • TOR Serine-Threonine Kinases
  • piperine